DALLAS, April 16, 2025 (GLOBE NEWSWIRE) -- Triumph Financial, Inc. (Nasdaq: TFIN) has released its first quarter 2025 financial results. The 1Q 2025 financial results and shareholder letter are ...

The Sustainability Report, published as part of the Report of the Board of Directors, is prepared in accordance with the European Sustainability Reporting Standards (ESRS). PricewaterhouseCoopers Oy ...

Good morning, and thanks for joining us for Fulton Financial's conference call and webcast to discuss our earnings for the first quarter ending March 31, 2025. Your host for today's conference call is ...

In addition to a strong lineup of presenters, Doheny will also be well represented as SriniVas R. Sadda, MD, closes out his term as president of ARVO at the culmination of the 2025 meeting. Dr. Sadda ...

Brian Wieser, a principal at the consulting firm Madison and Wall, said Trump’s actions on tariffs led him to lower his ad-spending forecast for 2025. He sees ad spending growing by 3.6% in 2025, down ...

A live Video Webinar of the event can be accessed under the "Events and Presentations" section of Strategy's investor relations website at . The Video Webinar will be conducted on the Zoom platform ...

NEW YORK, April 14, 2025 /PRNewswire/ -- S&P Global (NYSE: SPGI) will hold its Annual Meeting of Shareholders on May 7, 2025 at 8:00 a.m. ( ...

Santander helped over 52,500 businesses and entrepreneurs through its non-financial proposition in 2024 ...

We are now accepting proposals for presentations at the 2025 Annual Conference which will be held in person at RUSI’s headquarters in London on 16 September. The UK PONI Annual Conference is the ...

Multiple presentations demonstrate that T-knife's ... at the upcoming American Association for Cancer Research (AACR) Annual Meeting taking place from April 25-30, 2025 in Chicago, IL.

Annual Meeting, taking place April 25 - 30 in Chicago. In an oral presentation, Lilly, in collaboration with Foghorn Therapeutics, will present new preclinical data for LY4050784, a selective ...

Erasca will also present potential first-in-class examples of direct SMP complex inhibitors, representing a new approach to block the RAS/MAPK pathway SAN DIEGO, March 25, 2025 (GLOBE NEWSWIRE ...